Clinical Trials List
Protocol NumberCOAV101B12301
Completed
2021-11-01 - 2026-02-09
Phase III
Terminated1
ICD-10G12.9
Spinal muscular atrophy, unspecified
ICD-9335.10
Spinal muscular atrophy, unspecified
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Principal Investigator
Yuh-Jyh Jong
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
7-10 participants
-
Global
125 participants
